A new strategy to manage some more advanced prostate cancers is proving successful, Elizabeth Tracey reports

Share:

Listens: 0

Health Newsfeed – Johns Hopkins Medicine Podcasts

Science


The combination of a drug called abiraterone with others routinely used in prostate cancer helps men with one stage of the disease remain disease free longer, two new studies find. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, explains. Nelson: What they found was that both the abiraterone containing arms in each […]